[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340863-105":3,"doc-detail-340863-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","foxa2-initiated-transcriptional-activation-of-inhba-induced-by-methylmalonic-acid-promotes-pancreatic-neuroendocrine-neoplasm-progression","FOXA2‑initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression","","Pancreatic neuroendocrine neoplasms (PanNENs) are highly heterogeneous tumors where neuroendocrine differentiation coexists with frequent metastasis, driving major tumor-related mortality. Metabolic alterations are linked to metastatic capacity, yet the molecular mechanism connecting metabolism to PanNEN progression remains unclear. This study identifies methylmalonic acid (MMA) as an oncometabolite promoting progression via an MMA-triggered EMT program. Inhibin βA (INHBA) is characterized as a key regulator activated by FOXA2 and followed by MITF-driven EMT gene regulation, validated in vitro and in vivo, nominating a metabolic therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/foxa2-initiated-transcriptional-activation-of-inhba-induced-by-methylmalonic-acid-promotes-pancreatic-neuroendocrine-neoplasm-progression/340863/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/foxa2-initiated-transcriptional-activation-of-inhba-induced-by-methylmalonic-acid-promotes-pancreatic-neuroendocrine-neoplasm-progression/340863.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does methylmalonic acid (MMA) play in PanNEN progression?","Question",{"text":63,"@type":64},"MMA is identified as an oncometabolite that promotes pancreatic neuroendocrine neoplasm progression. It triggers a potentially novel mechanism involving epithelial–mesenchymal transition (EMT).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is INHBA involved in MMA-induced PanNEN progression?",{"text":68,"@type":64},"INHBA is characterized as a key regulator of MMA-induced PanNEN progression through transcriptomic analysis, validated in vitro and in vivo. MMA activates INHBA as part of the progression pathway.",{"name":70,"@type":61,"acceptedAnswer":71},"How does FOXA2 connect MMA exposure to EMT-related gene regulation?",{"text":72,"@type":64},"INHBA activation is mediated by FOXA2, a neuroendocrine-specific transcription factor initiated during MMA-induced progression. MMA-induced INHBA upregulation then activates downstream MITF to regulate EMT-related genes in PanNEN cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340863,1790786464,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253",8,"Cellular and Molecular Life Sciences (2024) 81:50  \n[https://doi.org/10.1007/s00018-023-05084-0](https://doi.org/10.1007/s00018-023-05084-0) Cellular and Molecular Life Sciences  \nFOXA2‑initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression  \nChunhua Hu1 · MujieYe1 · Jianan Bai1 · Pengfei Liu2 · Feiyu Lu1 · Jinhao Chen1 · Yanling Xu1 · Lijun Yan1 · Ping Yu1 · Zequan Xiao3 · Danyang Gu1 · Lin Xu1 · YeTian1 · Qiyun Tang1  \nReceived: 25 July 2023 / Revised: 1 December 2023 / Accepted: 6 December 2023 © The Author(s) 2024  \nAbstract  \nPancreatic neuroendocrine neoplasms (PanNENs) are a group of highly heterogeneous neoplasms originating from the endocrine islet cells of the pancreas with characteristic neuroendocrine differentiation, more than 60% of which represent metastases when diagnosis, causing major tumor-related death. Metabolic alterations have been recognized as one of the hallmarks of tumor metastasis, providing attractive therapeutic targets. However, little is known about the molecular mechanism of metabolic changes regulating PanNEN progression. In this study, we first identified methylmalonic acid (MMA) as an oncometabolite for PanNEN progression, based on serum metabolomics of metastatic PanNEN compared with nonmetastatic PanNEN patients. One of the key findings was the potentially novel mechanism of epithelial–mesenchymal transition (EMT) triggered by MMA. Inhibin βA (INHBA) was characterized as a key regulator of MMA-induced PanNEN progression according to transcriptomic analysis, which has been validated in vitro and in vivo. Mechanistically, INHBA was activated by FOXA2, a neuroendocrine (NE) specific transcription factor, which was initiated during MMA-induced progression. In addition, MMA-induced INHBA upregulation activated downstream MITF to regulate EMT-related genes in PanNEN cells. Collectively, these data suggest that activation of INHBA via FOXA2 promotes MITF-mediated EMT during MMA inducing PanNEN progression, which puts forward a novel therapeutic target for PanNENs.  \nChunhua Hu, Mujie Ye, Jianan Bai, and Pengfei Liu contributed equally to this work.  \nExtended author information available on the last page of the article  \nGraphical abstract  \nMethylmalonic acid (MMA), a serum oncometabolite, increased the expression of inhibin βA (INHBA) by the neuroendocrine-specific transcription factor, FOXA2 to induce MITF-mediated EMT during the progression of pancreatic neuroendocrine neoplasms (PanNENs), providing an actionable therapeutic vulnerability to metabolic therapy in PanNENs.  \nKeywords Metabolic alterations · Tumor progression · Pancreatic neuroendocrine neoplasm · FOXA2 · INHBA · Epithelial–mesenchymal transition  \nIntroduction  \nPancreatic neuroendocrine neoplasms (PanNENs) are a group of highly heterogeneous neoplasms originating from the endocrine islet cells of the pancreas with characteristic neuroendocrine differentiation [1] . Although PanNEN is the second most common type of pancreatic neoplasm, which accounts for 3–5% of all cases, the annual incidence is increasing more rapidly than any other histological type of pancreatic tumor [2]. While PanNEN was initially  \nconsidered quite rare, the incidence has increased approximately fivefold over the past decades in the Surveillance, Epidemiology, and End Results (SEER) population-based database [3] . While PanNEN is often perceived as indolent, which is less aggressive than pancreatic ductal adenocarcinomas (PDAC), the prevalence of distant metastases at the time of initial diagnosis in PanNEN is surprisingly high (over 60%), and cancer-related death is generally caused by distant metastases [4 , 5] . The liver is the most common site of metastasis with 50–80% of PanNENs  \nhaving hepatic involvement, which might be explained by the classic “anatomical/ mechanical” hypothesis [6 , 7] . The median overall survival (OS) of PanNEN patients in SEER is 235 months for pat","cbCaip4MSdhBRkV4","https://ap.wps.com/l/cbCaip4MSdhBRkV4","pdf",18392381,20,"English","# Abstract\n# Introduction\n## PanNEN epidemiology and prognosis\n## EMT as a first step of metastasis\n## Metabolic alterations and oncometabolites","[{\"question\":\"What role does methylmalonic acid (MMA) play in PanNEN progression?\",\"answer\":\"MMA is identified as an oncometabolite that promotes pancreatic neuroendocrine neoplasm progression. It triggers a potentially novel mechanism involving epithelial–mesenchymal transition (EMT).\"},{\"question\":\"How is INHBA involved in MMA-induced PanNEN progression?\",\"answer\":\"INHBA is characterized as a key regulator of MMA-induced PanNEN progression through transcriptomic analysis, validated in vitro and in vivo. MMA activates INHBA as part of the progression pathway.\"},{\"question\":\"How does FOXA2 connect MMA exposure to EMT-related gene regulation?\",\"answer\":\"INHBA activation is mediated by FOXA2, a neuroendocrine-specific transcription factor initiated during MMA-induced progression. MMA-induced INHBA upregulation then activates downstream MITF to regulate EMT-related genes in PanNEN cells.\"}]","FOXA2‑initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression | PDF",1790039234,50,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a7e2b3d1ee74e45f1b4af968fb0abf7.webp",983,1305,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b57149bffb3b2a5bab61449bab7c50f.webp",982,1304,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8035ebbb9d296f88ea22f1e797509b9.webp",981,1303,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c284bbc011588193f61ba8c7b4e15750.webp",980,1301,{"code":4,"msg":82,"data":117},[118,122,126,130,135,139,143,146,150,153,157],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":98,"slug":138},6,"Technology","technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":140,"show_sort_weight":141,"slug":142},"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":144,"slug":145},30,"research-report",{"id":147,"doc_module":4,"doc_module_name":25,"category_name":148,"show_sort_weight":92,"slug":149},9,"Religion & Spirituality","religion-spirituality",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":151,"show_sort_weight":92,"slug":152},"World Cup","world-cup",{"id":154,"doc_module":4,"doc_module_name":25,"category_name":155,"show_sort_weight":154,"slug":156},10,"Lifestyle","lifestyle",{"id":158,"doc_module":4,"doc_module_name":25,"category_name":159,"show_sort_weight":131,"slug":160},19,"General","general"]